The SARS-CoV-2 spike protein induces long-term transcriptional perturbations of mitochondrial metabolic genes, causes cardiac fibrosis, and reduces myocardial contractile in obese mice-Reference-Cited by-同舟云学术

The SARS-CoV-2 spike protein induces long-term transcriptional perturbations of mitochondrial metabolic genes, causes cardiac fibrosis, and reduces myocardial contractile in obese mice

Published:2023-08 Issue: Volume:74 Page:101756
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

Cao Xiaoling,Nguyen Vi,Tsai Joseph,Gao Chao,Tian Yan,Zhang Yuping,Carver Wayne,Kiaris Hippokratis,Cui Taixing,Tan Wenbin

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference65 articles.

1. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2;Nat Microbiol,2020

2. Structure, function, and antigenicity of the sars-cov-2 spike glycoprotein;Walls;Cell,2020

3. Neuropilin-1 facilitates sars-cov-2 cell entry and infectivity;Cantuti-Castelvetri;Science,2020

4. Neuropilin-1 is a host factor for sars-cov-2 infection;Daly;Science,2020

5. The spike protein of sars-cov-2 induces heme oxygenase-1: pathophysiologic implications;Singh;Biochim Biophys Acta, Mol Basis Dis,2022

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spike Protein of SARS-CoV-2 Activates Cardiac Fibrogenesis through NLRP3 Inflammasomes and NF-κB Signaling;Cells;2024-08-11

2. Mitochondria in COVID-19: from cellular and molecular perspective;Frontiers in Physiology;2024-06-21

3. Induction of the inflammasome by the SARS-CoV-2 accessory protein ORF9b, abrogated by small-molecule ORF9b homodimerization inhibitors;2024-06-03

4. Challenges and opportunities in long COVID research;Immunity;2024-06

5. SARS-CoV-2 Spike Protein 1 Causes Aggregation of α-Synuclein via Microglia-Induced Inflammation and Production of Mitochondrial ROS: Potential Therapeutic Applications of Metformin;Biomedicines;2024-05-31